Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07800520 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Characterization of CB1 Receptors Using [11-C]OMAR in Opioid Use Disorder

Name: Characterization of CB1 Receptors Using [11-C]OMAR in Opioid Use Disorder — clinical trial record (NCT07800520)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 1

SponsorYale University

Started2026-09

View on ClinicalTrials.gov ↗

Yale University

487 trials monitored

See 35 trials at risk

The goals of this sub-study is to assess CB1R availability in early abstinent individuals with OUD (following opioid agonist therapy - OAT stabilization) and in matched healthy controls.

Trial Details

NCT Number	NCT07800520
Lead Sponsor	Yale University Collaborators: National Institute on Drug Abuse (NIDA)
Conditions	Opioid Use Disorder, OAT
Enrollment	110 participants
Start Date	2026-09
Primary Completion	2030-08 (estimated)
Study Completion	2030-08 (estimated)
Updated on ClinicalTrials.gov	2026-09-10